Pharmaceutical Company Assistance Programs

Pharmaceutical Company Assistance ProgramsPlease Note: The information on this page is the same as some of the information on the Financial Support page. This page was created in hopes of make the information about pharmaceutical company assistance programs easier to find. Please see Financial Support page for more treatment financial support information.

Pharmaceutical Company Assistance

Pharmaceutical companies also have Financial Assistance programs for people undergoing their specific treatments. For more information on these programs, check out the links below, call the numbers provided, or talk with your healthcare provider about eligibility requirements:

AbbVie Care
Canadians prescribed Holkira Pak (ombitasvir/paritaprevir/ritonavir and dasabuvir) or Technivie (ombitasvir/paritaprevir/ritonavir) or Maviret (glecaprevir/pibrentasvir) can request to be enrolled in AbbVie Care. The program is designed to provide a wide range of customized services including reimbursement assistance, education, and ongoing disease management support. AbbVie Care will not only support people living with hepatitis C throughout their treatment but healthcare professionals as well. For more information, contact your doctor, nurse, or call the program at: 1-844-471-2273.

Bristol-Myers Squibb Canada’s CLAIRE Program
Canadians prescribed Daklinza (daclatasvir) combined with either Sovaldi (sofosbuvir) or Sunvepra (asunaprevir), and in some cases ribavirin, can request to be enrolled in the CLAIRE patient support program. The CLAIRE patient support program was designed to help patients seek coverage and provide access to a customized list of services. It was designed so that one person will take care of each patient through the program’s duration. For more information, contact your doctor, nurse, or contact the program at: 1-844-HCV-2559 (phone number), 1-844-FAX-2559 (fax number), (email address).

Gilead’s Momentum Patient Assistance Program
To assist eligible HCV patients in Canada with access to Harvoni  (ledipasvir and sofosbuvir), Sovaldi (sofosbuvir), Epclusa (sofosbuvir and velpatasvir), Vosevi (sofosbuvir, velpatasvir and voxilaprevir) to the Gilead Momentum Support Program, which provides information to patients and healthcare providers to help facilitate patient access to medication.  For more information regarding the Momentum Support Program in Canada, please call 1-855-447-7977 or speak with your doctor or nurse.

Ibavyr Patient Support Program
Canadians prescribed ribavirin (Ibavyr) as part of their hep C treatment have the opportunity to request to be enrolled in the Ibavyr Patient Support Program. For more information, contact your doctor, nurse, or call the program at: 1-844-602-6858.

Janssen’s Galexos: Bioadvance Program
Janssen Inc. has created the Galexos: Bioadvance Program, which is a patient support program designed to provide patient health information and reimbursement assistance for patients who have been prescribed Galexos (simeprevir). This specialized patient support program represents a service offered at no cost to the patient and is fully confidential. For more information , contact your doctor, nurse, or call the program at: 1-855-512-3740.

Merck Care Program
For those who are prescribed Zepatier or pegylated interferon and ribavirin (Pegasys) there is Merck Care Program. For more information, contact your doctor, nurse, or call the program at: 1-866-872-5773.

PEGAssist Patient Support Program
Hoffmann-La Roche Inc. offers this patient assistance program for people who have been prescribed pegylated interferon (Pegasys) as part of their hepatitis C treatment. For more information, contact your doctor, nurse, or call the program at: 1-877-734-2797.